Nikki Zhang is a Director at Kleiner Perkins Caulfield & Byers China. Since joining the team in 2016, she has focused on investments in life sciences and healthcare areas.
Nikki has extensive experience in both biotech and medical device sectors. Before joining KPCB China, Nikki worked at Zimmer Biomet Inc., where she took multiple leadership roles to manage the company’s global trauma business and post-merger integration projects. Earlier in her career, Nikki was a business development manager at Hutchison MediPharma, where she specialized in corporate planning, global licensing and strategic partnership management.
Nikki holds an M.B.A. from The Fuqua School of Business of Duke University. She also received an M.A. in Biotechnology from Columbia University and a B.S. in Biochemistry from The University of Texas at Austin.